Astellas Pharma
Andrew Chilelli is a healthcare professional with extensive experience in health economics and outcomes research, particularly within the oncology sector. Currently serving as the Director of Health Economics and Outcomes Research for Established Markets at Astellas Pharma since August 2018, Andrew has also held various roles at the company, including Associate Director positions focusing on multiple cancer types. Prior to Astellas, Andrew worked at GlaxoSmithKline in several capacities related to clinical study management and medical research. Additionally, Andrew has academic experience as a Teaching Laboratory Coordinator at the University of Toronto and holds three advanced degrees, including a Master's degree in Health Technology Assessment from The University of Sheffield and two Master's degrees from the University of Toronto in Health and Biotechnology.
This person is not in any teams
This person is not in any offices
Astellas Pharma
42 followers
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the Americas and around the world.